Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
By Dawn ME Bowdish, Canada Research Chair in Aging & Immunity, McMaster University
Ishac Nazy, Associate Professor of Medicine and Scientific Director of McMaster Platelet Immunology Laboratory , McMaster University
Answers to key questions about rare blood clots linked to AstraZeneca's COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
Read complete article
© The Conversation
- Monday, May 31, 2021